Banday S, Mishra A, Rashid R, Ye T, Ali A, Li J
Nat Commun. 2025; 16(1):1267.
PMID: 39894896
PMC: 11788431.
DOI: 10.1038/s41467-025-56632-0.
Sigorski D, Sejda A, Abualsaud N, Krawczyk E, Izycka-Swieszewska E, Kitlinska J
Cancer Metastasis Rev. 2025; 44(1):21.
PMID: 39760953
PMC: 11703900.
DOI: 10.1007/s10555-024-10237-z.
Qian D, Wang X, Lv T, Li D, Chen X
Discov Oncol. 2024; 15(1):741.
PMID: 39625524
PMC: 11615168.
DOI: 10.1007/s12672-024-01645-2.
McGinnis J, Enriquez A, Vandiver F, Bai X, Kim J, Kilgore J
bioRxiv. 2024; .
PMID: 39554175
PMC: 11566046.
DOI: 10.1101/2024.10.27.620498.
Tlemsani C, Heske C, Elloumi F, Pongor L, Khandagale P, Varma S
iScience. 2024; 27(6):109781.
PMID: 38868205
PMC: 11167437.
DOI: 10.1016/j.isci.2024.109781.
Seclidemstat blocks the transcriptional function of multiple FET-fusion oncoproteins.
Rask G, Taslim C, Bayanjargal A, Cannon M, Selich-Anderson J, Crow J
bioRxiv. 2024; .
PMID: 38826330
PMC: 11142045.
DOI: 10.1101/2024.05.19.594897.
EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma.
Yasir M, Park J, Chun W
Int J Mol Sci. 2023; 24(20).
PMID: 37894854
PMC: 10607184.
DOI: 10.3390/ijms242015173.
Targeted Therapy for EWS-FLI1 in Ewing Sarcoma.
Gong H, Xue B, Ru J, Pei G, Li Y
Cancers (Basel). 2023; 15(16).
PMID: 37627063
PMC: 10452796.
DOI: 10.3390/cancers15164035.
NK2 homeobox gene cluster: Functions and roles in human diseases.
Mio C, Baldan F, Damante G
Genes Dis. 2023; 10(5):2038-2048.
PMID: 37492711
PMC: 10363584.
DOI: 10.1016/j.gendis.2022.10.001.
Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer.
Heylen E, Verstraete P, Van Aerschot L, Geeraerts S, Venken T, Timcheva K
Br J Cancer. 2023; 128(10):1862-1878.
PMID: 36932191
PMC: 10147615.
DOI: 10.1038/s41416-023-02216-y.
Integrative analyses of bulk microarray data to discover genes, pathways, and immune infiltration characteristics associated with targeting of Ewing sarcoma.
Cao B, Sun H, Fan Z, Khawar M, Cai L, Yu S
J Cancer Res Clin Oncol. 2023; 149(10):6967-6977.
PMID: 36849756
PMC: 10374716.
DOI: 10.1007/s00432-023-04642-0.
Screening for DAX1/EWS-FLI1 functional inhibitors identified dihydroorotate dehydrogenase as a therapeutic target for Ewing's sarcoma.
Watanabe M, Kosaka H, Sugawara M, Maemoto M, Ono Y, Uemori T
Cancer Med. 2023; 12(8):9802-9814.
PMID: 36825574
PMC: 10166890.
DOI: 10.1002/cam4.5741.
Human EWS-FLI protein recapitulates in Drosophila the neomorphic functions that induce Ewing sarcoma tumorigenesis.
Molnar C, Reina J, Herrero A, Heinen J, Mendiz V, Bonnal S
PNAS Nexus. 2023; 1(4):pgac222.
PMID: 36714878
PMC: 9802468.
DOI: 10.1093/pnasnexus/pgac222.
Regulation of EWSR1-FLI1 Function by Post-Transcriptional and Post-Translational Modifications.
Yu L, Davis I, Liu P
Cancers (Basel). 2023; 15(2).
PMID: 36672331
PMC: 9857208.
DOI: 10.3390/cancers15020382.
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma.
Lu D, Ellegast J, Ross K, Malone C, Lin S, Mabe N
Nat Cell Biol. 2023; 25(2):285-297.
PMID: 36658220
PMC: 9928584.
DOI: 10.1038/s41556-022-01059-8.
Slit2 signaling stimulates Ewing sarcoma growth.
Suvarna K, Jayabal P, Ma X, Shiio Y
Genes Cancer. 2022; 13:88-99.
PMID: 36533189
PMC: 9753566.
DOI: 10.18632/genesandcancer.227.
The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review.
Apfelbaum A, Wrenn E, Lawlor E
Front Oncol. 2022; 12:1044707.
PMID: 36505823
PMC: 9727305.
DOI: 10.3389/fonc.2022.1044707.
Ewing and Ewing-like sarcomas: A morphological guide through genetically-defined entities.
Yoshida A
Pathol Int. 2022; 73(1):12-26.
PMID: 36484765
PMC: 10107474.
DOI: 10.1111/pin.13293.
AT-hook DNA-binding motif-containing protein one knockdown downregulates EWS-FLI1 transcriptional activity in Ewing's sarcoma cells.
Kitagawa T, Kobayashi D, Baron B, Okita H, Miyamoto T, Takai R
PLoS One. 2022; 17(10):e0269077.
PMID: 36194562
PMC: 9531837.
DOI: 10.1371/journal.pone.0269077.
TrkC, a novel prognostic marker, induces and maintains cell survival and metastatic dissemination of Ewing sarcoma by inhibiting EWSR1-FLI1 degradation.
Kim M, Lee W, Lee H, Jin W
Cell Death Dis. 2022; 13(9):836.
PMID: 36171207
PMC: 9519565.
DOI: 10.1038/s41419-022-05275-w.